Moberg Pharma builds momentum ahead of European launches

MOB-015, Moberg Pharma’s topical nail fungus treatment, has spent the past two years building a market-leading position in Sweden and Norway under the brand Terclara®, sold through the company’s partner Allderma.

That Nordic track record is now the foundation for a wider international rollout, with Karo Healthcare as the central partner.